Laser treatment of the retina has been the standard care
for diabetic macular edema since an NEI - supported study in 1985 showed it to be beneficial.
Regeneron Pharmaceuticals this week reported positive results from two phase 3 trials of Eylea (aflibercept) injection
for diabetic macular edema (DME).
«Drugs are effective
for diabetic macular edema new trial shows.»
Not exact matches
This AI was designed to flag advanced AMD or
diabetic macular edema for urgent treatment, and to refer less severe cases
for routine checkups.
VEGF inhibitors have been used
for several years to treat
diabetic macular edema, a swelling of the retina that can occur as blood leaks around it.
The finding could lead to the development of new drugs
for wet
macular degeneration and
diabetic macular edema.
The anti-vascular endothelial growth factor drugs ranibizumab and aflibercept, used to treat vision loss from
diabetic macular edema (DME), and approximately 20 to 30 times more expensive than bevacizumab, are not cost - effective
for treatment of DME compared to bevacizumab unless their prices decrease substantially, according to a study published online by JAMA Ophthalmology.
Because Lucentis is commonly injected to treat
diabetic macular edema (DME)-- a build - up of fluid in the center of the retina — the study permitted the use of Lucentis
for DME in the laser group, if necessary.
«These results indicate a treatment breakthrough
for saving the vision of people with
diabetic macular edema,» said Neil M. Bressler, M.D., chair of the DRCR.net and chief of the Retina Division at the Wilmer Eye Institute, Johns Hopkins University.
Additional inhibitors targeting this pathway are under development by multiple pharmaceutical companies
for this genetic disease and other conditions, including
diabetic macular edema.